ArticleData in brief2020
Data on the sequence-derived properties of gastric cancer - binding peptides.
Article in Data in brief, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The article presents a dataset containing nine classes of calculated sequence-derived descriptors for 78 peptide sequences, 21 of which demonstrate the ability to bind with gastric cancer cells. The datasaet was used in the paper "A screening algorithm for gastric cancer binding peptides" [1] for the creation of a classification model that can predict the ability of a given peptide sequence to bind with gastric cancer cells. The 78 peptide sequences were extracted from a systematic literature search, and the various peptide descriptors were calculated using the R package "Peptides". The nine calculated sequence-derived descriptor classes are the Blosum indices, Cruciani properties, FASGAI vectors, Kidera factors, ProtFP, ST-scales, T-scales, VHSE scales, and Z-scales. The resulting dataset, which is composed of over 4000 data points, offers a rich resource for further protochemometric analyses of the curated peptide sequences relevant to cancer diagnostics and therapeutics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.